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ABSTRACT 
 
Probiotics are getting its popularity due to its possible health benefits such as 
antimicrobial activity, alleviating diarrhea, anticarcinogenic properties, improving lactose 
intolerance and immune system. Therefore, various food products containing probiotics have 
been marketed including yogurt, milk powder and frozen desserts. However, those health 
benefits are strain specific and no single strain has all of the proposed health benefits. Also, 
many probiotics containing food products are fail to maintain the recommended probiotics 
concentration, which is 10
6
 CFU/g of food product, due to instability of probiotics in food 
matrices. Therefore, microencapsulation using spray drying has been used as an effective method 
for protecting probiotics from harsh environments and controlled release at desired conditions 
increasing the applicability of probiotics in various food products. Although atomization is a 
critical step for spray drying operation, the choice of atomization method has not been based on 
availability as well as experience but based on general acceptance that one atomization is better 
than the other. Therefore, the objectives of this study was to 1) evaluate the effect of atomization 
methods on survivability of bacterial cells during microencapsulation process and storage and 2) 
evaluate the effect of microencapsulation on viability of selected probiotics for storage and 
simulated gastrointestinal tract. In order to accomplish these objectives, two different 
atomization methods and wall matrices were tested to determine an optimal process to 
encapsulate probiotics. Then viability of probiotics during microencapsulation process, storage 
and simulated GI tract was evaluated. Results showed that microencapsulation was significantly 
effective for probiotics during the process, long-term storage and simulated GI tract. Especially, 
whey protein concentrate (WPC) and two-fluid nozzle atomization were significantly effective to 
maintain viable counts of probiotics during simulated GI tract.               
iii 
 
ACKNOWLEDGEMENTS 
 
I would like to thank my advisor, Dr. Youngsoo Lee, for all of his guidance and support 
during my researches and studies. My research would not have been completed without his 
encouragement and direction. I would also like to thank my committee members, Dr. Michael 
Miller and Dr. Graciela Padua, for their invaluable advisement and contributions to my research. 
Also, I would like to express my appreciation to all lab members including my lab, sensory lab 
and Miller lab members for all of their support, help and friendship during my studies. Special 
thanks to my friends in Korea for their encouragement and advice during all of my studies 
including undergraduate years. Lastly, I would like to thank my family for their love, 
encouragement and financial support throughout my studies.           
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
TABLE OF CONTENTS 
 
List of Tables                                                                                                                                  v 
List of Figures                                                                                                                                vi 
Chapter 1. Introduction ............................................................................................................... 1 
1.1 Motivation ............................................................................................................................. 1 
1.2 Objectives .............................................................................................................................. 2 
1.3 References ............................................................................................................................. 3 
Chapter 2. Literature Review ...................................................................................................... 4 
2.1 Probiotics ............................................................................................................................... 4 
2.2 Microencapsulation ............................................................................................................... 9 
2.3 References ........................................................................................................................... 16 
Chapter 3. Effect of wall matrices and atomization methods on survivability of bacteria 
during microencapsulation process and storage ...................................................................... 21 
3.1 Abstract ............................................................................................................................... 21 
3.2 Introduction ......................................................................................................................... 22 
3.3 Materials and Methods ........................................................................................................ 24 
3.4 Results and Discussion ........................................................................................................ 28 
3.5 Conclusions ......................................................................................................................... 31 
3.6 References ........................................................................................................................... 32 
3.7 Tables and Figures .............................................................................................................. 34 
Chapter 4. Effect of microencapsulation on viability of probiotics during storage and in 
simulated gastrointestinal tract ................................................................................................. 42 
4.1 Abstract ............................................................................................................................... 42 
4.2 Introduction ......................................................................................................................... 43 
4.3 Materials and Methods ........................................................................................................ 45 
4.4 Results and Discussion ........................................................................................................ 50 
4.5 Conclusions ......................................................................................................................... 57 
4.6 References ........................................................................................................................... 57 
4.7 Tables and Figures .............................................................................................................. 60 
Chapter 5. Summary .................................................................................................................. 73 
v 
 
LIST OF TABLES  
Table 2.1 Techniques and processes used for encapsulating probiotic microorganisms ............. 13 
Table 3.1 Operation conditions for spray drying ......................................................................... 34 
Table 3.2 Viability of E. lactis on each step during encapsulation process ................................. 36 
Table 4.1 Operation conditions for spray drying ......................................................................... 60 
Table 4.2 Viability of B. infantis on each step during encapsulation process .............................. 61 
Table 4.3 Relative humidity (RH) of ambient air during encapsulation process. ........................ 64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF FIGURES 
Figure 2.1 Morphology of different types of microcapsules ....................................................... 10 
Figure 3.1 Flow diagram of microencapsulation process ............................................................ 34 
Figure 3.2 Schematic diagram of spray drying system ................................................................ 35 
Figure 3.3 Two types of atomizers............................................................................................... 35 
Figure 3.4 Viability of E. lactis after encapsulation process ....................................................... 36 
Figure 3.5 Mean reduction of E. lactis after encapsulation process ............................................ 37 
Figure 3.6 Mean viable counts changes of E. lactis during storage............................................. 38 
Figure 3.7 Mean reduction of viable counts during 3 weeks storage .......................................... 39 
Figure 3.8 Mean reduction of viable counts during 25 weeks storage. ....................................... 40 
Figure 3.9 Scanning electron micrographs (SEM) of encapsulated E. lactis .............................. 41 
Figure 4.1 Flow diagram of microencapsulation process ............................................................ 60 
Figure 4.2 Viability of B. infantis after encapsulation process .................................................... 61 
Figure 4.3 Mean reduction of B. infantis after encapsulation process ......................................... 62 
Figure 4.4 Viable counts changes of B. infantis during storage .................................................. 63 
Figure 4.5 Viable counts changes of B. infantis in simulated gastrointestinal model ................. 64 
Figure 4.6 Viability of B. infantis after simulated gastrointestinal model test ............................ 65 
Figure 4.7 Mean reduction of B. infantis after simulated gastrointestinal model test ................. 66 
Figure 4.8 Viability of B. infantis and LA-5 after encapsulation process ................................... 67 
Figure 4.9 Mean reduction of B. infantis and LA-5 after encapsulation process ........................ 68 
Figure 4.10 Viable counts changes of LA-5 (wpc+nozzle) in simulated gastrointestinal model 69 
Figure 4.11 Viability of B. infantis and LA-5 after simulated gastrointestinal model test .......... 70 
Figure 4.12 Viability of B. infantis and LA-5 after simulated gastrointestinal model test .......... 71 
vii 
 
Figure 4.13 Scanning electron micrographs of encapsulated B. infantis (A-D) and LA-5 (E) .... 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter 1. Introduction 
1.1 Motivation 
Probiotics are referred as “live microorganisms, which when administered in adequate 
amounts confer a health benefit on the host” (Food and Agriculture Organization/World Health 
Organization 2001). The popularity of probiotic has continuously been growing and various food 
products have been marketed. Majority of commercial probiotics are Lactobacillus and 
Bifidobacteria species used in products such as yogurt, milk powder and frozen desserts (Shah 
2007). It has been known that probiotics have many health benefits such as antimicrobial activity, 
alleviating diarrhea, anticarcinogenic properties, improving lactose intolerance and immune 
system (Saavedra and others 1994; Marteau and others 1997; Shah 2000; Cenci and others 2002; 
Shah 2007). However, those health benefits are strain specific and no single strain has all of the 
proposed health benefits (Shah 2007). 
Although there is no specific standard for required probiotics concentration for maximum 
health benefits for different species and strains, the minimum dose of probiotics believed to exert 
health benefits is 10
6 
CFU/g of food product at the time of consumption in general (Robinson 
1987). This concentration could be strain specific and the number of survived cells during GI 
tract is more important. However, many probiotics containing food products are fail to maintain 
the recommended probiotics concentrations due to instability of probiotics in food matrices 
(Shah and others 1995).  So there is a need to find a technique to improve the stability of 
probiotics in food matrices. 
Microencapsulation has been used as an effective method for protecting probiotics from 
harsh environments and controlled release at desired conditions. Among various methods, spray 
drying has widely been used as an effective method due to low operating cost and large-scale 
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production (Picot and Lacroix 2003). Atomization is a critical step for spray drying operation. 
Centrifugal atomization and nozzle atomization have widely been used in industries. Centrifugal 
atomizer atomizes liquids with a spinning disk. Liquid is fed onto the center of the disk, and the 
whirling motion forces the liquid outward in thin sheets to cause atomization (Masters 1985). 
Nozzle atomizes liquids by means of compressed air. Nozzle can be located in the cone of drying 
chamber (counter-current) or at the ceiling of the chamber as co-current with the hot air (Masters 
1985). It was generally accepted that one atomization is better than the other for each application, 
and the choice of atomization method has not been based on availability as well as experience.  
While encapsulation of probiotics has been widely studied for their effectiveness, the 
atomization methods have not to be thoroughly studied with evaluation on their effects on core 
materials such as probiotics.   
 
1.2 Objectives 
The first objective of this research was to evaluate the effect of atomization methods on 
survivability of bacterial cells during microencapsulation process and storage. The second 
objective was to evaluate the effect of microencapsulation on viability of selected probiotics for 
storage and simulated gastrointestinal tract.  
In order to accomplish these objectives, two different atomization methods and wall 
matrices were first tested to determine an optimal process to encapsulate probiotics. Viability of 
probiotics was evaluated by enumeration of probiotic cells for different treatments. Storage test 
was also conducted for evaluating decrease in viable counts over time. Finally, simulated 
gastrointestinal model test was conducted for viability of probiotics to determine the 
effectiveness of microencapsulation.    
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Chapter 2. Literature Review  
2.1 Probiotics 
Probiotics  
Probiotics have been defined as “live microorganisms which when administered in 
adequate amounts confer a health benefit on the host” (Food and Agriculture Organization/World 
Health Organization 2001). Probiotics can be obtained from human and animal intestinal tracts, 
but currently, the most successful strains are from human origin (Saarela and others 2000). 
Probiotics have several characteristics in safety, technology, and functionality aspects. For safety, 
the following characteristics should be considered; 1) strains for human use are preferably from 
human origin, 2) strains should be non-pathogenic, 3) strains should not deconjugate bile salts 
since bile salt deconjugation or dehydroxylation would negatively affect the small intestines 
(Marteau and others 1995), and 4) strains should not carry transmissible antibiotic resistance 
genes (Saarela and others 2000). In terms of technological aspects of probiotics, good sensory 
properties, phage resistance, viability during processing and stability in the product should be 
considered (Saarela and others 2000). There are several functionality aspects of probiotics such 
as; 1) acid tolerance for human gastric juice, 2) bile tolerance to survive in the small intestines, 3) 
adherence to epithelial surfaces for effective colonization and 4) persistence in the human 
gastrointestinal (GI) tract (Saarela and others 2000). 
Among these characteristics, functional aspects of probiotics should be considered when 
selecting preferable probiotic strains for specific purpose. Based on their functionalities, 
probiotics are selected and used to obtain benefits from consumption. For example, 
Streptococcus thermophilus and Lactobacillus delbrueckii ssp. Bulgaricus have been used as 
starter cultures for making yogurt. Nowadays, the majority of commercial probiotics are 
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Lactobacillus and Bifidobacteria species used in products including yogurt, milk powder and 
frozen desserts since these species have a long history in the manufacture of dairy product, have 
been considered safe, and also are found as a part of gastrointestinal microflora (Shah 2007).  
Lactobacillus are naturally antibiotic resistant (Charteris and others 1998), aero-tolerant 
and acid-tolerant (Anal and Singh 2007). They are strictly fermentative and lactic acid is the 
major end-product of sugar fermentation (Axelsson 1993). Among many species of lactic acid 
bacteria, L. acidophilus is the most widely used as probiotics (Shah 2007). Bifidobacteria are 
normal inhabitants of the human gastrointestinal tract (Shah 2007) and strictly anaerobic. 
Typically, new born babies have high number of Bifidobacteria in their intestines and the 
population is stable until advanced age, but it decreases due to diet, antibiotics and stress (Shah 
2007). Probiotics need to be viable when consumed and survive gastric transit in order to reach 
to distal intestine to generate their health benefits.  
 
Health Benefits 
It has been known that probiotics have many health benefits, but some benefits are well 
established than the others, which have shown promising results in animal studies (Shah 2007). 
Also, these benefits are strain specific. In other words, no single strain has all of the proposed 
health benefits (Shah 2007). Various health benefits that can be provided by the consumption of 
probiotics are as follows. First, probiotics have antimicrobial activity. Organic acid, especially 
lactic acid and acetic acid, hydrogen peroxide and bacteriocins produced from fermentation of 
probiotic bacteria are antimicrobial substances which suppress the proliferation of pathogenic 
bacteria by lowering pH in the gut (Shah 2007). Second, probiotics are effective on alleviating 
diarrhea. Probiotics are claimed to shorten duration of children’s diarrhea caused by rotavirus, 
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which is one of the most common factors causing acute diarrhea in children (Saavedra and others 
1994). From their studies, infected children had significantly lower rate of rotaviral shedding 
after consumption of B. bifidum and S. thermophilus. Third, probiotics are effective to improve 
lactose intolerance. L. delbrueckii ssp. bulgaricus and Streptococcus thermophilus contain β-ᴅ-
galactosidase, which is an enzyme helps to hydrolyze lactose into glucose and galactose (Shah 
2000a). Forth, probiotics have anticarcinogenic properties. L. acidophilus, Bifidobacterium, L. 
plantarum and L. rhamnosus produce short chain fatty acids which prevent the formation of 
carcinogenic products by reducing activities of some enzymes such as β-glucuronidase, 
azoreductase and nitroreductase (Cenci and others 2002). Fifth, probiotics are effective for peptic 
ulcer prevention and improvement. Peptic ulcers are caused by Helicobacter pylori, which 
normally present in stomach without causing any adverse effects for healthy individuals 
(Armuzzi and others 2001). Probiotics have not been shown to eradicate H. pylori compared to 
antibiotics treatments, but they have shown to help reduce the colonization of H. pylori, prevent 
growth, and reduce inflammation (Felley and others 2001; Cats and others 2003). Lastly, it has 
reported that probiotics may directly or indirectly influence the improvement of immune function 
(Marteau and others 1997). Recent researches have displayed the effectiveness of probiotics on 
immunity. L. acidophilus strain NCFM (also called Howaru® Dophilus) was shown to prevent 
urogenital infection with subsequent exposure to E. coli, Klebsiella pneumonia and 
Pseudomonas aeruginosa (Sanders and Klaenhammer 2001) and L. plantarum was shown to 
have positive effect on immunity in HIV+ children (Walker 2000). 
 
Current use of probiotics in food industry 
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The application of probiotics in food matrix is a growing field in food industry. Among 
many products, yogurt has been the most popular and important carrier of probiotic bacteria. The 
estimated total U.S. retail sales of yogurt and yogurt drinks in 2011 are $6.4 billion/year and the 
yogurt industry is expected to grow to $9.5 billion/year by 2016 (Mintel Reports 2011). Also, at 
least 281 new yogurt products with claims of inclusion of probiotics were launched in U.S. 
between 2005 and 2010, and over 1,400 yogurt products have been launched in U.S. since 2005 
(Mintel Reports 2010). Cheese-based dips could be prepared with probiotics due to its stable pH 
and presence of prebiotics (Tharmaraj and Shah 2004). Also, Cheddar cheese could provide a 
good protection to probiotic bacteria during storage due to its higher pH, more solid consistency 
and relatively higher fat content (Ong and others 2006). Furthermore, there are many probiotics 
supplements which are in capsule or powder forms having sufficient concentration of probiotics 
on market.                   
 
Viability  
Although there are no specific standards and a firm guide for required probiotics 
concentration for different species and strains, the minimum dose of probiotics believed to exert 
health benefits is 10
6 
CFU/g of food product at the time of consumption in general (Robinson 
1987). However, this concentration could be different depending on probiotic strains and the 
more important thing is that the number of survived cells during GI tract. Many probiotics 
containing food products fall far short of the recommended probiotics concentrations due to 
instability of probiotics in food matrices (Shah and others 1995). L. acidophilus have shown 
better survivability compared to traditional yogurt starter cultures such as L. delbrueckii ssp. 
bulgaricus and Streptococcus thermophilus, but it has been observed to have rapid decrease in 
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number under acidic conditions both in vitro and in vivo (Conway and others 1987). 
Bifidobacterium spp. is not as acid-tolerant as L. acidophilus. Therefore, the growth rate is 
significantly slower than L. acidophilus under pH 5.0 (Shah 1997). Researches have shown that 
survivability of probiotics in yogurt can be affected by several factors including; 1) acidity of 
products, 2) acid produced during refrigerated storage, 3) oxygen level in products, 4) oxygen 
permeation through the package, 5) antimicrobial substances produced by starter bacteria and 6) 
lack of nutrients in milk and yogurt mix (Lankaputhra and Shah 1995; Dave and Shah 1997a; 
Dave and Shah 1997b; Shah 2000b). 
To improve the viability of probiotic bacteria, several methods have been proposed. First, 
the use of oxygen-impermeable containers has shown better survivability for both L. acidophilus 
and Bifidobacteria (Dave and Shah 1997b). Since L. acidophilus is microaerophilic and 
Bifidobacterium spp. are anaerobic, survivability of those probiotics is affected by dissolved 
oxygen content in yogurt. The research has shown that yogurt stored in glass bottles which have 
less oxygen content had 30 to 70% higher survival rate of L. acidophilus and Bifidobacterium 
spp. than plastic containers (Dave and Shah 1997b). Second, two-step fermentation is beneficial 
for increasing probiotics concentration. During fermentation, yogurt starter cultures grow faster 
than probiotic bacteria, therefore, probiotics lose their viability due to acids produced by yogurt 
starter cultures (Shah 2000b). Lankaputhra and Shah (1997) studied that initial fermentation with 
probiotic bacteria followed by fermentation with yogurt bacteria showed higher counts by 
allowing the probiotic bacteria to be in their final stage of lag phase or early stage of log phase 
which could dominate the flora (Lankaputhra and Shah 1997). Third, incorporation of 
micronutrients such as amino acids and peptides helps improving probiotics survivability. Dave 
and Shah (1998) added whey protein concentrate (WPC) in yogurt and checked the viability of 
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probiotics. Their results showed that WPC improved the viability of Bifidobacterium. Based on 
the results, they suggested that a nitrogen source in the form of peptides and amino acids 
improved the viability of Bifidobacterium (Dave and Shah 1998). Lastly, microencapsulation has 
suggested as an effective method to improve viability of probiotics (Gismondo and others 1999).             
 
2.2 Microencapsulation 
Microencapsulation 
Microencapsulation is defined as a technology of packaging solids, liquids, or gaseous 
materials in miniature, sealed capsules that can release their contents at controlled rates under 
specific conditions (Shahidi and Han 1993). The purpose of encapsulation is to protect core 
materials which are easily harmed in undesired environments. Possible benefits of 
microencapsulation are; 1) protection and stabilization of core materials, 2) utilization of 
sensitive food components, 3) prevention of nutritional loss, 4) extending shelf life,  5) 
controlling the oxidative reaction, 6) providing sustained or controlled release at desired 
environment, 7) masking and preserving flavors, aromas and colors and 8) transforming liquids 
into solid which are easier to handle (Shahidi and Han 1993; Anal and Singh 2007).  
Microencapsulation has been developed approximately 40 years ago and widely used in 
the food industry due to its capabilities to provide good protection from moisture, heat or other 
extreme conditions which are undesirable factors for maintaining stability and viability of core 
materials (Gibbs and others 1999). Food ingredients such as flavoring agents, acids, bases, 
artificial sweeteners, colorants, preservatives, leavening agents and antioxidants can be 
encapsulated. Also, nutrients, enzymes, cells or other materials can be the core materials (Gibbs 
and others 1999). Wall material can be selected from various materials depending on the method 
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of microencapsulation used and interaction with core material. Some materials that are widely 
used as wall materials in the food industry are sugars, gums, proteins, natural and modified 
polysaccharides, lipids and synthetic polymers (Gibbs and others 1999).   
Generally, microcapsules have diameter in range of approximately 5 to 300 m (Lee 
1996). However, they can be formed in many different shapes such as a simple wall coating, a 
multiwall structure, a wall of spherical or irregular shaped and numerous cores within the same 
walled structure as shown in Figure 2.1 (Gibbs and others 1999). Both size and shape of 
microcapsules vary depending on the method and materials used to produce the capsules 
(Gharsallaoui and others 2007).        
 
 
FIGURE 2.1: Morphology of different types of microcapsules (Gibbs and others 1999) 
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Methods of microencapsulation 
Microcapsules can be produced by various techniques. One of the techniques for 
microencapsulation is spray drying. Spray drying has been widely used in the food industry due 
to low operation cost, wide availability of equipment and easy scale-up (Gharsallaoui and others 
2007). For procedure of spray drying, first, homogenized liquid materials are fed into a spray 
dryer and atomized by centrifugal atomizer or nozzle. Then, the liquid is immediately dried by 
hot air flow in the chamber of spray dryer. After dried, the encapsulated particles are collected in 
cyclone of the spray dryer. Since the atomized liquid in chamber has short contact time with heat 
during drying, spray drying is proper encapsulation method especially for labile materials such as 
flavors (Vidhyalakshmi and others 2009).   
Extrusion is another physical method of microencapsulation.  In extrusion technique, a 
rotating extrusion head with concentric nozzles encapsulate liquids (Vidhyalakshmi and others 
2009). Since the core material is totally isolated by the wall material, it gives good protection and 
improved stability. Therefore, extrusion is effective encapsulation method for flavors, vitamin C, 
colors and especially for dry food applications such as drink, cake, cocktail and gelatin dessert 
mixes (Gibbs and others 1999). 
Fluidized bed coating is also used for producing microcapsules. Coating material is 
atomized on top of solid particles which are suspended in chamber of high velocity air under 
controlled temperature and humidity (Dezarn 1995). The amount of coating material on capsule 
can be regulated by controlling the length of time that the particles are in the chamber (Gibbs and 
others 1999). This application can be used for many fortified foods, nutritional mixes and dry 
mixes. For example, citric acid, lactic acid, sorbic acid, vitamin C, sodium bicarbonate in baked 
goods, and salt added to pretzels and meats (Gibbs and others 1999).   
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Coacervation is a physicochemical method for microencapsulation. First step is the 
formation of immiscible chemical phases. A liquid phase of coating material is separated from a 
polymeric solution. Then, the liquid polymer coating is deposited around the core material by 
controlled physical mixing in manufacturing vehicle (Shahidi and Han 1993). The microcapsules 
are collected by filtration or centrifugation followed by washing with an appropriated solvent. 
After that, the capsules are dried by spray drying or fluidized bed drying to be solidified (Shahidi 
and Han 1993). Although coaervation is an efficient technique, it is expensive (Gibbs and others 
1999). Therefore, it has been in limited use for flavor encapsulation (Shahidi and Han 1993).     
           
Microencapsulation of probiotics 
As mentioned earlier, probiotics are naturally weak to maintain enough number needed 
for having possible health benefits under specific environment such as acidic pH, oxygen and 
concentrated sugar from fermentation. For example, probiotics in fermented frozen dairy desserts 
have shown poor survivability in such products (Ravula and Shah 1998). Therefore, probiotics 
need to be modified for expanded and efficient applications.  
Microencapsulation has widely been used in the food industry to improve the viability of 
probiotics. There are several techniques of microencapsulation of probiotics as shown in Table 
2.1 (Anal and Singh 2007). 
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Microencapsulation techniques Types of materials for coating 
Spray drying Water-soluble polymers 
Spray-congealing Waxes, fatty acids, water-soluble and water-insoluble 
polymers, monomers 
Fluidized-bed coating/air suspension Water-insoluble and water-soluble polymers, lipids, 
waxes 
Extrusion Water-soluble and water-insoluble polymers 
Coacervation/phase separation  Water-soluble polymers 
Electrostatic method Oppositely charged polymers/compounds 
TABLE 2.1: Techniques and processes used for encapsulating probiotic microorganisms 
(Anal and Singh 2007) 
 
Among several techniques, spray drying is considered as an effective method for 
probiotics microencapsulation due to low operating cost and large-scale production (Picot and 
Lacroix 2003b). The basic steps of encapsulation of probiotics using spray drying consist of 
preparation of emulsion to be processed, homogenization, atomization of the emulsion and 
dehydration of the atomized particles (Dziezak 1988; Shahidi and Han 1993). For emulsion 
preparation, probiotics mixed with hydrophobic materials (core material) are dispersed in 
hydrophilic materials (wall material). Then the emulsion is homogenized by pressure. In this step, 
hydrophobic materials including probiotics are captured inside the droplet by hydrophilic layer 
forming stable emulsion. After that, the emulsion is atomized in the chamber of spray dryer. 
Atomization is a critical step for spray drying operation. Centrifugal atomization and nozzle 
atomization have widely been used in industries. Centrifugal atomizer atomizes liquids with a 
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spinning disk. Liquid is fed onto the center of the disk, and the whirling motion forces the liquid 
outward in thin sheets to cause atomization (Masters 1985). Nozzle atomizes liquids by means of 
compressed air. Nozzle can be located in the cone of drying chamber (counter-current) or at the 
ceiling of the chamber as co-current with the hot air (Masters 1985). In previous studies, both 
atomization methods have been used without through evaluation on their effects on core 
materials such as probiotics.             
Selecting wall materials are important for encapsulation efficiency and stability of 
microcapsules. Wall material can be selected in many varieties based on its solubility, molecular 
weight, glass/melting transition, crystallinity, diffusibility, film forming and emulsifying 
properties (Gharsallaoui and others 2007). For spray drying, it is more important that wall 
material should be soluble in water since spray drying is carried out from aqueous feed 
formulation (Gouin 2004). Also, it should have good properties of emulsification and film 
forming and low viscosity (Reineccius 1988). Maintaining low viscosity of emulsion is 
important since high viscosity may impede the atomization process and cause formation of large 
droplets which adversely affect the drying rate (Rosenberg and others 1990). Several materials 
have studied as wall materials for encapsulating probiotic microorganisms using spray drying 
such as cellulose acetate phthalate (Favaro-Trindale and Grosso 2002), whey protein isolate 
(Picot and Lacroix 2003a; Picot and Lacroix 2004), gum arabic, gelatin, soluble starch (Lian and 
others 2002), β-cyclodextrin and acacia gum (Zhao and others 2008). Among many materials, 
proteins are the most commonly used as wall materials in microencapsulation since proteins have 
an amphiphilic characteristics offering physicochemical and functional properties required to 
encapsulate hydrophobic core materials (Gharsallaoui and others 2007). Moreover, protein 
compounds such as sodium caseinate, soy protein isolate, whey protein concentrates and isolates 
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could also be expected to have good properties for microencapsulation (Gharsallaoui and others 
2007).         
Microencapsulation by spray drying can produce large amounts of materials; therefore, it 
is economical and effective for mass production. However, most probiotic bacteria did not 
survive well during the drying process due to high heat and osmotic extremes (Selmer-Olsen and 
others 1999). Picot and Lacroix (2004) designed an alternative method for microencapsulation of 
probiotics by spray drying which directly disperse fresh cells in heat-treated whey protein 
suspension followed by spray drying (Picot and Lacroix 2004). From their research, 
Bifidobacterium breve R070 and Bifidobacterium longum R023 encapsulated using their method 
showed low survival rates which were 26% for B. breve and 1.4% for B. longum after spray 
drying, however, these capsules protected and controlled release of probiotics under simulated 
intestinal conditions (Picot and Lacroix 2004). 
Also, various polymer systems are used for encapsulating probiotics in gel entrapment 
method. Natural biopolymers such as calcium alginate, κ-carrageenan and gellan gum have been 
used for encapsulating materials for probiotics (Picot and Lacroix 2004). Spherical polymer 
beads can be produced by extrusion or emulsification techniques by thermal or ionotropic 
gelation of the droplets (Anal and Singh 2007). Using polymer systems has many benefits. 
Encapsulated beads are easy to handle and can be quantified allowing controlled dosage. Also, 
further surface coating can be applied which is related to sensory properties of the product and 
extra level of protection (Anal and Singh 2007). However, this method is very difficult for large-
scale production due to low production capacity, large bead size for the droplet extrusion 
methods, transfer from organic solvent and also processing costs are very high (Poncelet and 
Neufeld 1996; Picot and Lacroix 2003a).     
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Conclusions 
Probiotics are getting its popularity in food industry due to various health benefits which 
can be obtained by consuming specific probiotic strains. Various techniques for maintaining 
viability of probiotics have been suggested and applied. Microencapsulation, especially by spray 
drying, has widely been used for processing probiotics. Previous studies have tried many 
different strains with different methods including wall matrices and atomization methods of 
spray drying to show effectiveness of encapsulation. However, there is lack of studies evaluating 
the combined effects of wall matrices and atomization methods of spray drying on viability and 
stability of encapsulated probiotics. Therefore, the study of the effects of wall system and 
atomization methods on probiotics is valuable to establish effective encapsulation methods 
which may eventually exert maximum health benefits from probiotics consumption.     
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Chapter 3. Effect of wall matrices and atomization methods on survivability of bacteria 
during microencapsulation process and storage 
 
3.1 Abstract 
The popularity of probiotics is growing in food industry due to its health benefits and 
various food products containing probiotics have been marketed. Microencapsulation is a 
technique to improve viability of probiotics during processing and storage. The objective was to 
evaluate the effectiveness of wall matrices and atomization methods of spray drying on viability 
of microorganisms for microencapsulation process.  
Enterococcus lactis UI100 was used to test microencapsulation of microorganisms prior 
to work with probiotics. E. lactis was mixed with soybean oil for immobilization of bacterial 
cells. Then, it mixed with 10% denatured protein solution (SPC or WPC) by 1:9 ratio. The 
mixture was homogenized at 10342 kPa with single path using a two stage homogenizer to 
prepare emulsion. The emulsion was spray dried at inlet and outlet air temperatures of 160°C and 
90°C, respectively. Two different atomization methods, centrifugal atomization and two-fluid 
nozzle atomization, were used for spray drying. Dried samples were collected and stored for 
further analysis. Viability of encapsulated E. lactis was evaluated by enumeration on MRS agar.  
The microencapsulation was effective to maintain viable counts about 10
8
 CFU/ml after 
spray drying process for all samples with less than 1 log reduction. There was no significant 
difference (less than 0.2 log reduction for all samples) on viable counts for short-term storage, 
but two-fluid nozzle atomization had significantly less reduction (about 0.25 log reduction) than 
centrifugal atomization (about 1 log reduction) for long-term storage. The atomization methods 
dominated the differences in viability and morphology of microcapsules than the wall matrices 
(SPC/WPC).     
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3.2 Introduction 
Probiotics are live microorganisms that confer a health benefit on the host when 
administered in adequate amounts (Food and Agriculture Organization/World Health 
Organization 2001). Consuming probiotics is a growing area in the food industry. The majority 
of commercial probiotics are Lactobacillus and Bifidobacteria species used in products including 
yogurt, milk powder and frozen desserts since these species have a long and safe history in the 
manufacture of dairy product and also are found as a part of gastrointestinal microflora (Shah 
2007). Although there are no specific standards and a firm guide for required probiotics 
concentration for different species and strains, the minimum dose of probiotics believed to exert 
health benefits is 10
6 
CFU/g of food product at the time of consumption in general (Robinson 
1987). However, this minimum concentration for health benefits could be different depending on 
probiotic strains and the number of survived cells during GI tract is more important regarding the 
effectiveness of the products containing probiotics. 
Many probiotics containing food products are hard to maintain the recommended 
probiotics concentrations due to instability of probiotics in food matrices (Shah and others 1995). 
Among several methods suggested to improve the viability of probiotics, microencapsulation has 
widely been used due to its effectiveness. The main purpose of encapsulation is to protect core 
materials which are easily harmed in undesired environments by surrounding wall matrices until 
the core material is released at desired environment.    
Spray drying is widely used and considered as an effective method for probiotics 
microencapsulation due to low operating cost and large-scale production (Picot and Lacroix 
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2003). The basic steps of probiotics encapsulation using spray drying consist of preparation of 
emulsion, homogenization, atomization and dehydration of the atomized particles (Dziezak 1988; 
Shahidi and Han 1993). There are mainly two different types of atomization methods being used 
in spray drying; centrifugal and nozzle atomization. Centrifugal atomizer atomizes liquids with a 
rotating disk. Liquid is fed onto the center of the disk, and the whirling motion forces the liquid 
outward in thin sheets to cause atomization (Masters 1985). Nozzle atomizes liquids by means of 
compressed air. The nozzle can be located in the cone of drying chamber (counter-current) or 
ceiling (co-current with the hot air) of spray dryer (Masters 1985).  
Although centrifugal and nozzle atomization have been widely used in industries, Shahidi 
and Han (1993) mentioned that there is no supporting evidence of literature that one method 
results in better effect than the other. Each type of atomization has its advantages and 
disadvantages (Shahidi and Han 1993). Advantages of centrifugal atomization are ease of control 
over particle size by adjusting the rotation speed, low risk of getting choked and can be used in 
any chamber system (Cal and Sollohub 2010). However, it has drawbacks including wall 
deposits and needed to be used in wider chambers (Cal and Sollohub 2010). Two-fluid nozzle 
atomization produces a good dispersion of low viscosity liquids but with broad range of particle 
size distribution.  
Selection of wall materials is also very important since it is related to encapsulation 
efficiency and stability of microcapsules. Wall material can be selected in many varieties based 
on its solubility, molecular weight, glass/melting transition, crystallinity, diffusibility, film 
forming and emulsifying properties (Gharsallaoui and others 2007). Proteins are the most 
commonly used as wall materials in microencapsulation due to amphiphilic characteristics 
offering physicochemical and functional properties required to encapsulate hydrophobic core 
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materials (Gharsallaoui and others 2007). Young and others (1993) reported that whey proteins 
have been successfully used as a wall system to encapsulate anhydrous milk fat by spray drying 
with high encapsulation yield (greater than 90%) (Young and others 1993). Denatured whey 
proteins were shown to affect the functional properties of spray dried powder (Millqvist-Fureby 
and others 2001).      
Enterococcus is a genus of lactic acid bacteria (LAB) usually present in vegetables, plant 
material and food stuffs with animal origin such as dairy products (Giraffa 2003; Fisher and 
Phillips 2009). Among many strains, E. faecalis and E. faecium are common commensal 
organisms in human intestines (Gilmore 2002). However, utilization of Enterococci as probiotics 
is still controversial since some strains have been associated with human infections, several 
virulence factors and antibiotic resistance (Moreno and others 2006). In this study, E. lactis was 
used for testing microencapsulation of microorganisms by spray drying. 
The objective of this study was to evaluate the effectiveness of different wall matrices 
and atomization methods on viability of probiotics during microencapsulation process and also 
during storage.  
 
3.3 Materials and Methods 
Figure 3.1 schematically illustrates the microencapsulation process. 
Wall and Core Materials 
Soy protein concentrate (SPC, ARCON® S) containing 76.4% (w/w) protein was 
provided by Archer Daniels Midland (Decatur, IL, USA) and whey protein concentrate (WPC, 
Hilmar™ 8200) containing 82.5% (w/w) protein provided by Hilmar Ingredients (Hilmar, CA, 
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USA) were used as wall material. Soybean oil containing 99.9% (w/w) lipids was obtained from 
local market and used for dispersing microorganisms.        
 
Culture Preparations 
Enterococcus lactis strain UI100 was isolated from an environment sample and used for 
this research. Fresh cultures were prepared after two transfers in MRS (de Man, Rogosa and 
Sharpe) broth under anaerobic chamber (COY Laboratory Product Inc, MI, USA) containing 90% 
N2, 5% CO2 and 5% H2 at 37°C for 24 hours (per each transfer). Then, the MRS broth was 
divided into four separate plastic centrifuge bottles (capacity: 250mL) and centrifuged 
(Eppendorf 5810R Centrifuge, Eppendorf, Hamburg, Germany) with 3220 RCF (Relative 
Centrifugal Force, x g) for 10 min at 20°C. After centrifugation, supernatant was discarded and 
pellets were thoroughly mixed with soybean oil.    
 
Wall Material Preparation and Emulsification 
10% (w/w) SPC or WPC solutions were prepared using deionized water and then heat-
treated with agitation at 85°C for SPC and 80°C for WPC for 20 min using ThermoMix TM21 
(Vorwerk USA Co; Altamonte Spring, FL). The denatured protein solution was stored overnight 
(approximately 14 hours) at 4ºC and then reheated to 40ºC. While heating, the solution was 
continuously stirred and significant gel or chunks were broken down by being pressed on the 
wall of bucket. E. lactis dispersed in soybean oil were mixed with 10% SPC or WPC solution by 
1:9 ratio. Then, 1:9 blend of E. lactis plus soybean oil and SPC or WPC solutions were 
homogenized at 10342 kPa with single path by a two stage APV homogenizer (SPX Flow 
Technology, Denmark).  
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Microencapsulation by Spray Drying 
After homogenization, the emulsion was kept at 40°C until spray drying process 
(Anhydro Compact spray dryer, SPX Flow Technology, Denmark). To stabilize the spray drying 
system before running with the emulsion, deionized water was fed into the spray dryer when the 
inlet air temperature reached to 160°C as preset. Outlet air temperature was controlled to be 
about 90°C (±5°C) by controlling the feed rate. For atomization, two different types of atomizers 
were used. One was a centrifugal atomization. The diameter of the spinning disk was 10cm, and 
it had 8 small holes which had diameter of 0.4cm. The centrifugal atomization was operated at 
20,000 rpm. The second atomization method was a two-fluid nozzle atomization operated with 
compressed air at 344.7 kPa. After the spray drying was stabilized by maintaining the outlet air 
temperature at 90°C (±5°C), the deionized water was drained from feed tank and the emulsion 
was fed into the system. Inlet and outlet air temperatures were monitored during entire drying 
process. After spray drying, the encapsulated particles were collected in clear glass bottles with 
screw caps and stored at room temperature for further analyses. Table 3.1 shows the operation 
settings for spray drying system. Figure 3.2 and figure 3.3 show the spray drying system and 
atomizers. For control sample, non-encapsulated E. lactis were mixed with soybean oil and 
stored in the same glass bottles at room temperature for storage test same as other encapsulated 
samples. Proteins were not added to control sample to minimize the spoilage of the sample 
during the storage at room temperature.  
      
Bacterial Enumeration 
To evaluate viability of E. lactis during the microencapsulation process, samples were 
collected and enumerated on MRS agar from each stage of the process, which are initial cell 
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concentration, after mixing with soybean oil, after homogenization with protein solution and 
after spray drying. For non-powder samples, 1ml of sample from each stage was collected to 
make serial dilutions. Serial dilutions were prepared using sterile 0.1% peptone water and plated 
using Eddy Jet spiral-plater (IUL Instruments, Spain). For dried samples (after spray drying), 
0.5g of encapsulated powders were dispersed in 10ml of sterile 0.1% peptone water and evenly 
mixed by a vortex mixer for 1 min to make serial dilutions. Plates were incubated for 3 days in 
anaerobic conditions at 37°C. After counting CFU/ml at each stage, mean reduction of bacterial 
cells between initial state and after spray drying was analyzed.  
Storage tests were conducted to evaluate the effectiveness of microencapsulation on 
stability of bacterial cells during storage at ambient temperature. Samples stored in the glass 
bottles at room temperature were enumerated after 3 weeks of storage as a short-term storage test 
and after 25 weeks as a long-term storage test. Mean viable counts from the samples between 
after spray drying and each storage period were measured.             
 
Morphology of Microcapsules 
Encapsulated particles for scanning electron microscope (SEM) were prepared by 
attaching the particles to double-faced adhesive tape on SEM stubs, and then coating them with 
gold and palladium using turbo-pumped sputter coater (Denton Desk II TSC, Beckman Institute, 
Champaign, IL, USA). The sample was placed in SEM chamber and the surface structure of 
encapsulated particles was observed by an environmental scanning electron microscope (Philips 
XL30 ESEM-FEG, Beckman Institute, Champaign, IL, USA). 
 
Statistical Analyses 
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Analyses of variance (ANOVA) and significant differences among treatment means were 
analyzed using the Fisher’s Least Significant Difference (LSD) test with a probability level 
P<0.05 using Statistical Analysis Software (SAS) version 9.2 (SAS Institute, Inc.; Cary, N.C.). 
 
3.4 Results and Discussion 
Viability of Bacterial Cultures during Microencapsulation Process 
Table 3.2 shows the viable counts of the microencapsulated E. lactis at each step during 
the encapsulation process. All four samples had similar initial concentration at around 5x10
8
 
CFU/ml. At oil dispersion stage, the viable counts for all samples were decreased compared to 
the initial counts. It could be possible that the sample taken for plating did not contain 
homogeneous mixture because the oil and water were not mixed homogeneously by shaking. At 
homogenization stage, the numbers were slightly increased compared to the initial counts 
possibly due to increased homogeneity of the sample. Picot and Lacroix (2004) used milk fat and 
heat-denatured 10% whey protein isolate (WPC) solution for microencapsulation and showed 
that there was no loss in viability of Bifidobacterium breve and Bifidobacterium longum during 
emulsification step which indicates a negligible effect of shear forces on cell survival. After the 
spray drying, the results show that all numbers were significantly decreased from the initial 
numbers, and all samples still maintained viable counts at about 10
8
 CFU/ml.  
Figure 3.4 shows the viable counts of E. lactis before and after the encapsulation process. 
Viable counts of E. lactis for all four treatments decreased after encapsulation processes with 
reductions less than 1 log. The reductions were statistically significant (α = 0.05) but 
microcapsules still maintained E. lactis concentrations at around 10
8
 CFU/ml. This indicates that 
all treatments were effective enough to maintain the viable counts of E. lactis more than 10
6
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CFU/g which has been referred as the recommended minimum concentration for probiotic 
bacteria to exert health benefits (Robinson 1987).  
Figure 3.5 illustrates that there was no significant difference in viable counts between 
different wall matrices and also between different atomization methods. Reduction in viable 
counts during microencapsulation was less than 1 log for all samples. Also, there was no 
significant interaction (p=0.26) between wall matrices and atomization which means that there 
were no significant differences in reductions of viable counts of E. lactis between SPC and WPC 
under same atomization method.      
 
Viability of Bacterial Cultures during Storage 
 After encapsulation process, samples were stored in the glass bottles at room temperature 
for storage test. Storage tests were conducted to evaluate viability of the encapsulated E. lactis. 
Figure 3.6 shows that all encapsulated E. lactis samples maintained their viable counts above 10
8
 
CFU/ml after 3 weeks of storage. After 25 weeks, viable counts of all samples were decreased 
but still maintained more than 10
7
 CFU/ml. This result shows that the microencapsulation 
process using spray drying was effective to maintain the concentration of E. lactis during short-
term (3 weeks) and also long-term (25 weeks) storage periods.   
During 3 weeks of storage, all samples had less than 0.2 log reduction (Figure 3.7). There 
was no significant difference of different wall matrices and different atomization methods on the 
viability of E. lactis for 3 weeks. However, there was a significant interaction (p=0.03) between 
wall matrices and atomization methods.  
Figure 3.8 shows that there was a significant difference on the viability counts E. lactis of 
different atomization methods for the long-term (25 weeks) storage test. The long term 
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survivability of E. lactis was significantly higher in the microcapsules processed using the two-
fluid nozzle atomization than using the centrifugal atomization. The microcapsules processed 
using the centrifugal atomization showed approximately 1 log reduction while the microcapsules 
processed using the two-fluid nozzle atomization showed approximately 0.25 log reduction after 
the 25 weeks of storage. However, the viable counts of E. lactis were not significantly affected 
by wall matrices showing about 1 log reduction for both SPC and WPC. Also, there was no 
significant interaction (p=0.26) between wall matrices and atomization methods. Both 
atomization methods attend shear forces for atomizing liquid into fine particles. Centrifugal 
atomization creates shear forces by high speed rotating wheel, and two-fluid nozzle atomization 
also creates shearing forces between liquid surface and an high velocity gaseous medium 
(Masters 1968). Based on the results of the storage tests, the emulsion containing E. lactis was 
significantly affected by shear forces from centrifugal atomization than two-fluid nozzle 
atomization during long term storage but not as much during the encapsulation process or short 
term storage. The different wall matrices did not present significant effect on viability of E. lactis 
over 25 weeks storage. Control sample which is non-encapsulated E. lactis was also tested for its 
viability during storage. Control sample had about 10
8
 CFU/ml at initial, then was enumerated 
after 16 weeks of storage resulting in no viable counts.  
Hydrophobic substances have been reported as potential cell immobilization matrices 
since diffusion of H
+
, organic acids, water and oxygen across the membranes of lipid capsules is 
limited (Kim and Olson 1985; Modler and Villa-Garcia 1993; Champagne and others 1995; 
Sunohara and others 1995). Proteins possess good properties of film forming and emulsification 
ability which required for a wall material to limit the permeability of water and oxygen. 
(Rosenberg and Sheu 1996).The long-term storage test clearly indicates that the encapsulated 
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bacterial cells could maintain their viabilities during storage possibly due to improved protection 
from exposure to various environmental factors such as moisture and oxygen. 
 
Morphology of Microcapsules  
Figure 3.9 (A) - (D) show SEM micrographs of encapsulated E. lactis prepared with four 
different treatments. All samples had spherical shapes and the diameter of most particles was less 
than 50µm except a few big particles. For size, centrifugal atomization produced bigger and 
narrow size distributions than two-fluid nozzle atomization. The samples processed using the 
two-fluid nozzle atomization resulted in greater variance in size of particles. In terms of shape, 
centrifugal atomization method produced more globular, less wrinkled and less clustered 
particles than two-fluid nozzle atomization method. The different atomization methods created 
differences morphology of microcapsules. 
 
3.5 Conclusions 
 E. lactis was used in this study to evaluate the effectiveness of microencapsulation on the 
survival of microorganisms during process and storage. Microcapsules were prepared using 
protein wall matrices (SPC and WPC) and spray drying with two different types of atomization 
methods (centrifugal atomization and two-fluid nozzle atomization). The encapsulation process 
was effective resulting in less than 1 log reduction in viable counts of E. lactis during 
encapsulation process. Also the encapsulation technique was effective enough to protect E. lactis 
during 25 weeks of storage. The effects of the wall matrices were not significant for storage test. 
On the other hand, the atomization methods significantly affected the survival of E. lactis during 
storage, especially after 25 weeks, indicating that the two-fluid nozzle method protects the 
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bacteria better than the centrifugal atomization method.  In conclusion, atomization methods 
dominated the differences in the viability of E. lactis and the morphology of microcapsules 
compared to the wall matrices (SPC/WPC).  
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3.7 Tables and Figures  
FIGURE 3.1 Flow diagram of microencapsulation process. 
 
 
TABLE 3.1 Operation conditions for spray drying. 
Inlet air temperature 160°C 
Outlet air temperature 90°C 
Feed rate 10 kg/hr 
Feed temperature 40°C 
Atomizer rotation speed for centrifugal atomization 20,000 rpm 
Air pressure for two-fluid nozzle atomization 344.7 kPa (50 psi) 
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FIGURE 3.2 Schematic diagram of spray drying system. 
 
FIGURE 3.3 Two types of atomizers.  
                                 
(A) Centrifugal atomizer                                       (B) Nozzle atomizer    
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TABLE 3.2 Viability of E. lactis on each step during encapsulation process.  
 SPC + atomizer WPC + atomizer SPC + nozzle WPC + nozzle 
Initial cell 5.36E+08
a
 5.65E+08
b
 5.64E+08
b
 5.77E+08
a
 
Oil dispersion 3.50E+08
b
 1.73E+08
c
 3.42E+08
c
 8.69E+07
c
 
Homogenization 6.65E+08
a
 1.03E+09
a
 7.22E+08
a
 6.20E+08
a
 
Spray drying 2.08E+08
b
 1.98E+08
c
 3.44E+08
c
 2.97E+08
b
 
All values are in CFU/mL. Different superscripts indicate significant differences (α = 0.05). 
Atomizer means the centrifugal atomizer and nozzle means two-fluid nozzle.  
 
 
FIGURE 3.4 Viability of E. lactis after encapsulation process.  
 
Different superscripts indicate significant difference (α = 0.05) in numbers between initial and 
after spray drying process for each sample. Atomizer means the centrifugal atomizer and nozzle 
means two-fluid nozzle. 
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FIGURE 3.5 Mean reduction of E. lactis after encapsulation process. 
 
 
Different superscripts indicate significant difference (α = 0.05) in numbers. Atomizer means the 
centrifugal atomizer and nozzle means two-fluid nozzle. 
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FIGURE 3.6 Mean viable counts changes of E. lactis during storage. 
 
Different superscripts indicate significant difference (α = 0.05) in viable counts among 0, 3 and 
25 weeks for each sample. Atomizer means the centrifugal atomizer and nozzle means two-fluid 
nozzle. Control is non-encapsulated E. lactis mixed with oil. 
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FIGURE 3.7 Mean reduction of viable counts of E. lactis during 3 weeks storage.  
 
 
Different superscripts indicate significant difference (α = 0.05) in numbers. Atomizer means the 
centrifugal atomizer and nozzle means two-fluid nozzle. 
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FIGURE 3.8 Mean reduction of viable counts of E. lactis during 25 weeks storage.  
 
 
Different superscripts indicate significant difference (α = 0.05) in numbers. Atomizer means the 
centrifugal atomizer and nozzle means two-fluid nozzle. 
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FIGURE 3.9 Scanning electron micrographs (SEM) of encapsulated E. lactis. 
(A) SPC with centrifugal atomization                   (B) SPC with two-fluid nozzle atomization 
 
(C) WPC with centrifugal atomization                  (D) WPC with two-fluid nozzle atomization 
 
 
 
 
 
 
 
 
42 
 
Chapter 4. Effect of microencapsulation on viability of probiotics during storage and in 
simulated gastrointestinal tract  
 
4.1 Abstract 
Probiotics has been reported to have various health benefits but need to be protected due 
to intrinsically low survivability in harsh conditions such as human gastrointestinal tract. Our 
objective was to evaluate the effectiveness of microencapsulation on viability of probiotics for 
storage and in a simulated gastrointestinal tract condition.  
Bifidobacterium infantis ATCC 15697 (B. infantis) and Lactobacillus acidophilus strain 
LA-5 (LA-5) were encapsulated as fresh cultures by spray drying using soybean oil and 
denatured soy protein concentrate (SPC) and whey protein concentrate (WPC) as immobilization 
material. A centrifugal or a two-fluid nozzle atomization was used for atomization of emulsion 
for spray drying process. After dried powders were collected, samples were kept at room 
temperature for further analyses; a storage test and a simulated gastrointestinal (GI) test.      
Results showed that microencapsulation significantly improved viability of B. infantis 
and LA-5. The encapsulated B. infantis were maintained viability of approximately 10
4
 CFU/ml, 
significantly longer (about 11 weeks) than non-encapsulated B. infantis (all died within 2 weeks). 
The atomization methods did not significantly affect the viability of B. infantis during 
microencapsulation process. On the other hand, wall matrices caused significant difference on 
viability of B. infantis during the encapsulation process. From the simulated GI tests, the viable 
counts of B. infantis were significantly affected by wall matrices and atomization methods. B. 
infantis microencapsulated with WPC and two-fluid nozzle resulted in significantly less 
reductions than with SPC and centrifugal atomizatioer in the simulated GI tests. Different 
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atomization methods caused differences on morphology of microcapsules but viability of 
probiotics was not significantly affected by morphological differences. 
Keywords: probiotics, microencapsulation, spray drying, simulated gastrointestinal tract 
 
4.2 Introduction 
 Probiotics are referred as “live microorganisms, which when administered in adequate 
amounts confer a health benefit on the host” (Food and Agriculture Organization/World Health 
Organization 2001). Therefore, popularity of probiotic containing products are continuously 
growing due to possible health benefits including antimicrobial activity, alleviating diarrhea, 
anticarcinogenic properties, improving lactose intolerance and immune system (Saavedra and 
others 1994; Marteau and others 1997; Shah 2000; Cenci and others 2002; Shah 2007). However, 
those health benefits are strain specific and no single strain has all of the proposed health benefits 
(Shah 2007). Although there are no specific standards and a firm guide for required probiotics 
concentration for different species and strains, the minimum dose of probiotics believed to exert 
health benefits is 10
6 
CFU/g of food product at the time of consumption in general (Robinson 
1987). However, this concentration could be different depending on probiotic strains and the 
number of survived cells during human GI tract is more important in evaluating the effectiveness 
of food products containing probiotics. 
 Due to instability of probiotics in food matrices, many probiotics containing food 
products fall far short of the recommended probiotics concentrations (Shah and others 1995). 
Microencapsulation has widely been used due to its effectiveness of maintaining viability of 
probiotic cells. It is a technique to capture core material by wall material for protection from 
adverse environments and controlled release at desired conditions. Spray drying is the mostly 
44 
 
used method for microencapsulation in food industry since it is economic and able for large-scale 
production (Picot and Lacroix 2003). Centrifugal and nozzle atomization can be used for 
dispersing homogenized emulsion into fine droplets. A high speed rotating disk of centrifugal 
atomization forces emulsion to be dispersed outward in thin sheets by whirling motion (Masters 
1985). A nozzle can be located as counter-current or co-current with the hot air in spray drying 
chamber and atomizes liquids by compressed air (Masters 1985). Spray drying is good for 
encapsulating labile materials such as microorganisms  since the atomized droplets have short 
contact time (less than 10 sec) with hot air, so it can minimize thermal damage (Vidhyalakshmi 
and others 2009). Encapsulation wall materials for spray drying can be selected by considering 
solubility, molecular weight, glass/melting transition, crystallinity, diffusibility, film forming and 
emulsifying properties (Gharsallaoui and others 2007). Proteins are effective wall material since 
the amphiphilic characteristics are enable for encapsulating hydrophobic core materials 
(Gharsallaoui and others 2007).  
 Probiotics should be able to withstand the host’s natural barriers against ingested bacteria 
since viable and biologically active microorganisms are required to exert maximum health 
benefits at the target site in the host (Picot and Lacroix 2004). From previous studies, it has been 
reported that many strains of Bifidobacterium ssp. naturally lack the ability to survive in harsh 
acidic and bile concentrations such as what is found in the human gastrointestinal tract (Berrada 
and others 1991; Lankaputhra and Shah 1995). On the other hand, Lactobacillus species are 
considered intrinsically resistant to acidic conditions (Kos and others 2000; Corcoran and others 
2005). The objective of this study was to evaluate the effectiveness of microencapsulation on 
viability of probiotics for prolonged storage and for simulated gastrointestinal treatments. Also, 
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two different probiotic strains (B. infantis and LA-5) were encapsulated to compare the strain 
specific viability differences.  
 
4.3 Materials and Methods 
Figure 4.1 schematically illustrates the microencapsulation process. 
Wall and Core Materials 
Soy protein concentrate (SPC, ARCON® S) containing 76.4% (w/w) protein provided by 
Archer Daniels Midland (Decatur, IL, USA) and whey protein concentrate (WPC, Hilmar™ 
8200) containing 82.5% (w/w) protein provided by Hilmar Ingredients (Hilmar, CA, USA) were 
used as wall material. Soybean oil containing 99.9% (w/w) lipids was obtained from local market 
and used for dispersing microorganisms. 
 
Culture Preparations 
Bifidobacterium infantis ATCC 15697 (American Type Culture Collection, Manassas, 
VA, USA) and Lactobacillus acidophilus strain LA-5 (Chr. Hansen Inc., Milwaukee, WI, USA) 
were used for this research. Those probiotics were kept at -80°C as frozen stock until ready to be 
used. Fresh probiotic cultures were prepared from frozen stock at each experiment. After two 
transfers in MRS (de Man, Rogosa and Sharpe) broth for LA-5 and MRS broth supplemented 
with 0.05% (w/v) L-cysteine-HCl (MRS-C) for B. infantis under anaerobic chamber (COY 
Laboratory Product Inc., MI, USA) containing 90% N2, 5% CO2 and 5% H2 at 37°C for 24 hours 
(per each transfer), the MRS/MRS-C broth were divided into four centrifuge bottles having 
capacity of 250ml. After that, probiotic cells were collected by centrifugation (Eppendorf 5810R 
Centrifuge, Eppendorf, Hamburg, Germany) with 3220 RCF (Relative Centrifugal Force, x g) for 
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10 min at 20°C. Supernatant was discarded and soybean oil was added back to the centrifuge 
bottles. The oil and condensed cell mixture were then shaken thoroughly until all cell condensate 
was removed from the bottom of the centrifuge bottle.  
 
Wall Material Preparation and Emulsification 
Denatured protein solutions were prepared using SPC or WPC with deionized water by 
10% concentration (w/w). After thoroughly mixed by blender, the protein-water mixture was 
heat-treated with agitation at 85°C for SPC and 80°C for WPC for 20 minutes using ThermoMix 
TM21 (Vorwerk USA Co; Altamonte Spring, FL, USA). The denatured protein solution was 
stored overnight (about 14 hours) at 4ºC and then reheated to 40ºC with stirring. Significant gel 
or chunks in the solution were broken and removed by straining. Probiotics dispersed in soybean 
oil were mixed with 10% protein solution (SPC or WPC) by 1:9 ratio. Then, the 1:9 blends of 
probiotics plus soybean oil and protein solution were homogenized by an APV homogenizer 
(SPX Flow Technology, Denmark) at 10342 kPa with single path.  
 
Spray Drying of Cultures 
The homogenized emulsion was then spray dried using an Anhydro Compact spray dryer 
(SPX Flow Technology, Denmark) which has internal diameter 1.25 m. The emulsion was kept 
at 40°C until spray drying process. Before running with the emulsion, deionized water was fed 
into the spray dryer to stabilize the spray drying system. Inlet air temperature was maintained to 
160°C as preset and outlet air temperature was adjusted to be about 90°C (±5°C) by controlling 
the feed flow rate during the process. Average wet bulb and dry bulb temperature of ambient air 
were 21.2°C and 29.6°C respectively. The range of relative humidity of the ambient air was 
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37.5-59%. Two types of atomization methods were examined; centrifugal atomization at 20,000 
rpm with rotating disk having diameter of 10cm, 8 small holes with diameter of 0.4cm and two-
fluid nozzle atomization with compressed air at 344.7 kPa. After the drying conditions were 
stabilized, the emulsion was fed into the system. At the end of the spray drying process, the dried 
particles were collected in clear glass bottles with screw caps and stored at room temperature for 
further analyses. Table 4.1 shows the operation settings used for the spray drying process.  
For control sample, non-encapsulated B. infantis and LA-5 were mixed with the soybean 
oil and stored in the glass bottle with screw cap at room temperature for storage test as other 
encapsulated samples. The proteins were not added to control sample to minimize the spoilage of 
the sample during the storage at room temperature. 
 
Simulated Gastrointestinal Model 
To examine the survivability of the microencapsulated B. infantis and LA-5 under 
simulated gastrointestinal conditions, a method utilized by Picot and Lacroix (2004) was 
modified and performed (Picot and Lacroix 2004). The basic principle of this methodology 
involves exposing encapsulated and non-encapsulated probiotic cultures to simulated 
gastrointestinal conditions mimicking the transit of food from a low pH (about pH 1.9) 
environment in the stomach to a higher pH (about pH 7.5) environment in the small intestinal 
tract and monitoring total viable counts of probiotics through each step.   
The three main solutions used in this methodology included a simulated gastric juice, a 
simulated small intestinal juice, and a concentrated bile solution. The simulated gastric juice was 
prepared by mixing pepsin (Porcine gastric mucosa hydrolyzed powder, Sigma-Aldrich Co., St. 
Louis, MO, USA) in a ratio of 0.276 g/L in of 0.1N HCl, applying mild heat and agitation and 
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adjusting the pH to 1.9 using 4N NaOH. To prepare the simulated small intestinal juice 
pancreatin 5X (Pancreatin 5X, MP Biomedicals LLC, Solon, OH, USA) in a ratio of 1.95 g/L 
was placed in 0.02M sterile sodium phosphate buffer (Sigma-Aldrich Co., St. Louis, MO, USA) 
and mixed with mild heat to dissolve. Adjustments to pH did not need to be made for the 
simulated small intestinal juice, but pH was confirmed to be 7.5 each time. Finally to prepare the 
concentrated bile solution, bile extract powder (bile bovine, B3883, Sigma-Aldrich Co., St. Louis, 
MO, USA) in a ratio of 150 g/L was placed into sterilized deionized water. After mild heat and 
agitation was applied, the pH of the solution was adjusted with 1N NaOH to pH 7.5. The 
resulting bile solution after the pH adjustment was then filter sterilized (10 mL sterile syringe, 
Becton, Dickinson and Company, Franklin Lakes, NJ, USA; 0.22 µm pore size syringe filter, 
Fisher Scientific, Pittsburg, PA, USA). All solutions were prepared fresh daily. 
A shaking water bath (Tecator 1024 Shaking Water Bath, FOSS, Hillerød, Denmark) 
heated to 37°C was used for the experimental procedure. Four Erlenmeyer flasks were 
aseptically filled with 75 mL of the simulated gastric juice. Ten grams of the microencapsulated 
probiotics were added into the flasks, while 1 mL of the control (non-encapsulated fresh B. 
infantis or LA-5) mixed with soybean oil was added. Both of these amounts were decided to 
produce similar initial concentration of viable counts. After the addition into the simulated 
gastric juice, the solution was manually mixed to ensure uniform distribution using a sterile stir 
bar. Each flask was then inserted and secured into the shaking water bath and allowed to sit for 
60 minutes. After 60 minutes, the pH of the solution was raised to 7.5 with 4N and 1N NaOH. A 
sample of 2 mL was removed and stored on ice for 5 minutes to stop the reaction before 
enumeration. Then, 5 mL of sodium phosphate buffer (0.5M) and 2 mL of concentrated bile 
solution were added to each flask to mimic conditions in small intestine. The pH of the resulting 
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solution was adjusted to pH 7.5 and the volume to 90 mL using sterile deionized water. Finally, 
10 mL of simulated pancreatic juice was added to each flask to bring the final volume to 100 mL. 
The flasks were allowed to remain in the shaking water bath for 3 additional hours. At each hour, 
2 mL of sample was removed from each flask and enumerated for viable cell counts. 
 
Bacterial Enumeration 
Viability of B. infantis and LA-5 were evaluated at each stage of microencapsulation 
process; initial cell concentration, after mixing with soybean oil, after homogenization and after 
spray drying. For dried (encapsulated) samples, 0.5 g of encapsulated probiotics were dispersed 
in 10 ml of sterile 0.1% peptone water and mixed by vortexing for 1 min. Then 1 ml of each 
sample was taken for making serial dilutions. For non-powder samples, 1 ml of sample from 
each stage was taken for making serial dilutions. After that, selected dilutions were plated (50 µL) 
on MRS-C agar (B. infantis) and MRS agar (LA-5) using Eddy Jet spiral-plater (IUL Instruments, 
Spain). After 3 days of incubation in anaerobic conditions at 37°C, viable counts were calculated. 
Mean reduction of viable counts of probiotic cells between initial concentration and after spray 
drying process was analyzed for evaluating viability of probiotics.  
Storage tests were conducted for encapsulated B. infantis samples to evaluate the 
effectiveness of the microencapsulation process on stability of probiotic cells during the storage 
at room temperature. Samples stored in glass bottles with screw cap at room temperature were 
enumerated every week. Mean viability counts from the samples between right after spray drying 
and each storage period were analyzed. 
Viability of the encapsulated probiotics in the simulated gastrointestinal model was also 
evaluated. 2 ml of sample at each stage including after 60 min in the simulated gastric juice, after 
50 
 
1, 2, 3 hour in the small intestinal juice was collected and stored in ice for 5 min to stop the 
reaction. Then the samples were enumerated using the same methods described above.  
 
Morphology of Microcapsules 
The morphology of encapsulated B. infantis was observed with a scanning electron 
microscope (SEM). Samples were prepared by attaching to double-faced adhesive tape on SEM 
stubs, and then coated with gold and palladium using turbo-pumped sputter coater (Denton Desk 
II TSC, Beckman Institute, Champaign, IL, USA). Surface structure of encapsulated particles 
was observed by scanning electron microscope (Philips XL30 ESEM-FEG, Beckman Institute, 
Champaign, IL, USA). 
 
Statistical Analyses 
Analysis of variance (ANOVA)  and significant differences among treatment means were 
tested using the Fisher’s Least Significant Difference (LSD) test with a probability level P<0.05 
using Statistical Analysis Software (SAS) version 9.2 (SAS Institute, Inc.; Cary, N.C.). For 
comparison between encapsulated B. infantis and LA-5, t-test was conducted using EXCEL 
version 2010 (Microsoft, Redmond, WA, USA).    
 
4.4 Results and Discussion 
Viability of B. infantis during Microencapsulation Process 
Changes in viable counts of B. infantis at each step of the microencapsulation process are 
shown in Table 4.2. Initial cell concentrations were slightly different among samples with range 
of 3x10
8 – 2x109 CFU/ml. The viable counts of all samples were significantly (α=0.05) decreased 
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from the initial counts at oil dispersion stage because the samples were not homogeneous in the 
oil and water mixture. At the homogenization stage, viable counts were significantly increased 
compared to the oil dispersion stage, but the counts were similar to the initial viable counts due 
to improve homogeneity of the sample. All the viable counts were significantly decreased after 
the spray drying process compared to the initial counts. The reductions for all samples were 
approximately 2 log. Figure 4.2 shows change in the viable counts of B. infantis after the 
encapsulation process. There were significant differences between initial counts and after the 
spray drying for all samples. After the spray drying, all samples effectively maintained its 
viability of more than 10
6
 CFU/ml which is regarded as a minimum concentration for probiotics 
to exert health benefits (Robinson 1987). Figure 4.3 illustrates mean reduction of all samples 
during the encapsulation process. There was a significant difference between SPC and WPC 
samples in terms of reduction. The WPC samples had significantly more reductions (slightly 
more than 2 log reduction) compared to the SPC samples (slightly less than 2 log reduction), 
however, the magnitude of reduction was within 0.5 log across the samples.  
On the other hand, the atomization methods did not significantly affect viable counts of B. 
infantis. Both atomization methods generate shear forces when dispersing liquid to particles in 
different manners. High speed rotary wheel of centrifugal atomization creates shear forces and 
two-fluid nozzle atomization also has high frictional shearing forces between liquid surface and 
an high velocity gaseous medium (Masters 1968). This difference from the two different 
atomization methods did not affect the viable counts of B. infantis in the same wall matrices 
during the encapsulation process. Also, there was no significant interaction (p=0.43) between 
wall matrices and atomization methods. In this study with B. infantis, wall matrix was the main 
factor causing the difference in viable counts of B. infantis during the encapsulation process.   
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Viability of Encapsulated B. infantis during Storage 
Figure 4.4 shows the change of viable counts during the storage at room temperature. In 
general, the trend shows that viable counts were decreased from around 10
7
 CFU/ml (right after 
spray drying) to around 10
3
 CFU/ml (end of storage) over time. The decreasing rate of viable 
counts for each sample during storage might be affected by the relative humidity (RH) of 
ambient air which kept inside glass bottle during sample collection after spray drying. . Table 4.3 
shows RH of ambient air for each sample. Range of RH for all samples was 37.5 – 52.9%. There 
was a trend in duplicated samples that viable counts of sample with higher RH were decreased 
faster with bacterial contamination.   
Water absorption capacity in chamber of spray dryer decreases as the relative humidity of 
ambient air increases, therefore, the energy consumption to heat the air increases which causes 
decreasing thermal efficiency (Kajiyama and Park 2010). Water absorption capacity can be 
increased by raising the inlet air temperature; however, the inlet temperature for this study was 
set to 160°C. Therefore, the moisture in atomized particles was not perfectly dried under high 
RH of ambient air causing high water activity for the dried particles which may be detrimental to 
bacterial survival during storage due to acceleration of oxidation processes (Teixeira and others 
1995). 
Viable counts of the control (non-encapsulated B. infantis) sample were dramatically 
decreased within 2 weeks of the storage. This result clearly indicates that microencapsulation 
was effective to maintain viability of B. infantis over storage at room temperature.    
  
Viability in Simulated Gastrointestinal Conditions    
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Changes in viable counts of encapsulated B. infantis in simulated gastrointestinal (GI) 
tract are illustrated in figure 4.5. Overall, the viable counts were decreased from about 10
7
 
CFU/ml to 10
3
-10
5
 CFU/ml during 4 hours of the simulated GI treatment. Figure 4.6 shows that 
the viable cell counts of B. infantis between before and after total 4 hours of the simulated GI 
treatment were significantly different. WPC samples maintained viable counts of more than 10
5
 
CFU/ml after the simulated GI test, while the viable counts in SPC samples were dropped below 
10
5
 CFU/ml. The reduction in viable counts after the simulated GI test is illustrated in figure 4.7. 
The results show that there was a significant difference in viable counts of B. infantis between 
wall matrices and also between atomization methods. WPC had significantly less reduction 
(approximately 1 log) than SPC (approximately 3.5 log) and two-fluid nozzle atomization had 
significantly less reduction (less than 3 log) than centrifugal atomization (approximately 3.5 log). 
Also, there was a significant interaction (p=0.02) between wall matrices and atomization 
methods. Therefore, it can be assumed that WPC and two-fluid nozzle atomizations were more 
effective on protecting B. infantis during the simulated GI test.  
Picot and Lacroix (2004) studied viable counts change of encapsulated Bifidobacterium 
breve R070 (BB R070) and Bifidobacterium longum R023 (BL R023) during simulated GI tract.  
Initial counts for both strains were 10
8
 CFU/ml. After 6 hours in simulated small intestinal juice, 
the viable counts of BB R070 were 10
7
 CFU/ml and that of BL R023 were 10
4
 CFU/ml.     
Based on their results, whey protein microcapsules showed a resistance to the hydrolytic action 
of simulated gastric juice (for 30 min) but the capsules were totally digested in the simulated 
small intestinal juice within 3 hour (Picot and Lacroix 2004). This gastroresistant characteristic 
of whey protein had also been reported by Beaulieu and others (2002). They observed that whey 
protein beads were resistant during pepsin incubation for 30 minutes, but the beads were totally 
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degraded after 6 hours incubation in pancreatic media (Beaulieu and others 2002). As illustrated 
in Morr and Ha (1993), β-lactoglobulin, which is the major protein of whey, is known to be 
resistant to pepsin (Morr and Ha 1993). It is because the hydrophobic amino acids of β-
lactoglobulin are located in the internal core of its calyx-like structure (Papiz and others 1986), 
so the peptides bond of that hydrophobic amino acids are difficult to be attacked by pepsin 
(Beaulieu and others 2002). After treatment in simulated gastric juice, degradation in small 
intestinal juice would be mainly by proteases such as trypsin, chymotrypsin and elastase which 
catalyze the hydrolysis of the peptide bonds with different specificities (Beaulieu and others 
2002). Therefore, it can be concluded that microcapsules made of WPC may protect B. infantis 
during digestion in stomach and will be dissolved and release B. infantis in small intestines 
where the favorable place for colonization of bacterial cells.     
Two types of control (non-encapsulated) samples were prepared for the simulated GI test 
(figure 4.5). Both control samples had initial concentration of 10
9
 CFU/ml before the GI test. The 
control without soybean oil resulted in dramatic decline in viable counts with a 5 log reduction 
after 1 hour in the simulated gastric juice. Then all probiotic cells were dead after 1 hour 
treatment in simulated small intestinal juice. For the control with oil, it showed gradual decrease 
in viable counts with 4 log reduction after 2 hours of treatment in the simulated small intestinal 
juice. Then, after 3 hours of treatment, there were no viable counts of B. infantis. The soybean oil 
also provided an extra barrier which was effective, although less degree than microcapsules, on 
maintaining viability of probiotics cells in the simulated GI conditions.    
 
Viability comparison between B. infantis and LA-5   
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Lactobacillus acidophilus strain LA-5 was also encapsulated and tested in the simulated 
GI condition to compare the differences of viability from two probiotic strains.  From our 
previous study, the two-fluid nozzle atomization showed significant less reduction in viable cell 
counts of E. lactis during the long-term storage (25 weeks) and also had significant less 
reduction during simulated GI model test for B. infantis. Based on the result, the two-fluid nozzle 
atomization was chosen to produce microcapsules for this experiment. For wall matrix, WPC 
was selected since it was significantly  effective in maintaining viability of B. infantis than SPC 
during the simulated GI test.  
Figure 4.8 compares the change in viability of two different probiotic strains after the 
spray drying process. Initially, both strains had the viable counts of about 10
9
 CFU/ml, and after 
the spray drying, the viable counts were decreased to around 10
6
 CFU/ml. The differences in 
viable counts between initial and final concentration were significant for both samples. As 
illustrated in figure 4.9, there was no significant difference in mean reduction of viable counts 
between the two samples. B. infantis had about 2 log reductions and LA-5 had slightly more 
reduction about 3 log reductions after the spray drying. Figure 4.10 shows viable counts decrease 
during the simulated GI test for LA-5. Encapsulated LA-5 maintained its viability having 
concentration of 10
5
 CFU/ml after simulated GI test with about 1 log reduction. The control 
sample (LA-5 in oil) showed about 3 log reductions during the GI test. Although all samples 
including control and encapsulated LA-5 reached the viable counts of around 10
5
 CFU/ml, the 
control sample showed greater decreasing rate in viable counts compared to the encapsulated 
samples. The comparison of the simulated GI results between B. infantis and LA-5 is illustrated 
in figure 4.11 and 4.12. Both samples had significant differences on viable counts between initial 
and after spray drying but the reductions were not significantly different between the two strains. 
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It can be concluded that the encapsulation using WPC and two-fluid nozzle atomization was 
effective since both probiotics had maintained the viable counts of around 10
6
 CFU/ml after the 
process. Also, there was no significant difference in terms of effectiveness of microencapsulation 
between two probiotic strains since both samples resulted in similar reductions in viable counts 
during the encapsulation process and the simulated GI test. However, the control test in the 
simulated GI conditions shows that LA-5 was stronger than B. infantis during GI test. It has been 
reported that Bifidobacterium are strictly anaerobic and not as acid-tolerant as Lactobacillus 
(Shah 2007) while Lactobacillus are naturally antibiotic resistant, aero-tolerant and acid-tolerant 
(Charteris and others 1998; Anal and Singh 2007). Therefore, B. infantis would be naturally 
more susceptible to the environment than LA-5. The result of this study shows that B. infantis 
can be protected from environmental factors using microencapsulation to the similar degree of 
LA-5.      
                  
Morphology of Microcapsules  
To assess the morphological features of the microcapsules, encapsulated probiotic 
samples were observed under scanning electron microscope. Figure 4.13 shows SEM 
micrographs of encapsulated B. infantis (A-D) and LA-5 (E). All samples had spherical shape 
with diameter of less than 50 µm for most particles. The centrifugal atomization produced 
smoother surface, more globular and narrower size distributions than two-fluid nozzle 
atomization. The two-fluid nozzle atomization resulted in greater variance in size of particles and 
had wrinkled and clustered particles compared to the particles processed by the centrifugal 
atomization. The different atomization methods caused differences on morphology of 
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microcapsules, however, the viabilities of B. infantis and LA-5 were not significantly affected by 
morphological differences of microcapsules during spray drying, storage and simulated GI test.  
 
4.5 Conclusions 
Microencapsulation significantly improved the viability of B. infantis and LA-5. The 
encapsulated probiotics were maintained high number of viable counts significantly longer than 
the non-encapsulated probiotics. During microencapsulation process, atomization methods did 
not significantly affect on viability of B. infantis. On the other hand, wall matrices dominated 
significant difference on viability of B. infantis. For simulated GI model test, encapsulated 
probiotics showed significantly improved viability than non-encapsulated probiotics. Especially, 
WPC showed significantly less reductions in viable counts and two-fluid nozzle atomization also 
had significantly less reductions during simulated GI test. For morphological aspect, although 
different atomization methods caused significant differences on the morphology of 
microcapsules, the viability of probiotics was not significantly affected by morphological 
differences of microcapsules during spray drying, storage and simulated GI conditions.          
 
4.6 References 
Anal AK, Singh H. 2007. Recent advances in microencapsulation of probiotics for industrial 
applications and targeted delivery. Trends Food Sci.Technol. 18(5):240-51.  
Beaulieu L, Savoie L, Paquin P, Subirade M. 2002. Elaboration and characterization of whey 
protein beads by an emulsification/cold gelation process: Application for the protection of retinol. 
Biomacromolecules 3(2):239-48.  
Berrada N, Lemeland J, Laroche G, Thouvenot P, Piaia M. 1991. Bifidobacterium from 
Fermented Milks - Survival during Gastric Transit. J.Dairy Sci. 74(2):409-13.  
58 
 
Cenci G, Rossi J, Trotta F, Caldini G. 2002. Lactic acid bacteria isolated from dairy products 
inhibit genotoxic effect of 4-nitroquinoline-1-oxide in SOS-chromotest. Syst.Appl.Microbiol. 
25(4):483-90.  
Charteris W, Kelly P, Morelli L, Collins J. 1998. Antibiotic susceptibility of potentially probiotic 
Lactobacillus species. J.Food Prot. 61(12):1636-43.  
Corcoran B, Stanton C, Fitzgerald G, Ross R. 2005. Survival of probiotic lactobacilli in acidic 
environments is enhanced in the presence of metabolizable sugars. Appl.Environ.Microbiol. 
71(6):3060-7.  
FAO/WHO. 2001. Health and Nutritional Properties of Probiotics in Food including Powder 
Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on 
Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk 
with Live Lactic Acid Bacteria. 
Gharsallaoui A, Roudaut G, Chambin O, Voilley A, Saurel R. 2007. Applications of spray-
drying in microencapsulation of food ingredients: An overview. Food Res.Int. 40(9):1107-21.  
Kajiyama T and Park KJ. 2010. Influence of air parameters on spray drying energy consumption. 
Revista Brasileira de Productos Agroindustrials, Campina Grande. vol.12. n.1. p.45-54.   
Kos B, Suskovic J, Goreta J, Matosic S. 2000. Effect of protectors on the viability of 
Lactobacillus acidophilus M92 in simulated gastrointestinal conditions. Food Technology and 
Biotechnology 38(2):121-7.  
Lankaputhra WEV, Shah NP. 1995. Survival of Lactobacillus acidophilus and Bifidobacterium 
spp in the presence of acid and bile salts. Cultured Dairy Products Journal 30(3):2-7.  
Marteau P, Vaerman J, Dehennin J, Bord S, Brassart D, Pochart P, Desjeux J, Rambaud J. 1997. 
Effects of intrajejunal perfusion and chronic ingestion of Lactobacillus johnsonii strain La1 on 
serum concentrations and jejunal secretions of immunoglobulins and serum proteins in healthy 
humans. Gastroenterol.Clin.Biol. 21(4):293-8.  
Masters K. 1968. Spray Drying - Unit Operation Today. Industrial and Engineering Chemistry 
60(10):53-63.  
Masters K. 1985. Spray drying handbook. 4
th
 edition. London: George Godwin. 171-217. 
Morr C, Ha E. 1993. Whey-Protein Concentrates and Isolates - Processing and Functional-
Properties. Crit.Rev.Food Sci.Nutr. 33(6):431-76.  
Papiz M, Sawyer L, Eliopoulos E, North A, Findlay J, Sivaprasadarao R, Jones T, Newcomer M, 
Kraulis P. 1986. The Structure of Beta-Lactoglobulin and its Similarity to Plasma Retinol-
Binding Protein. Nature 324(6095):383-5.  
59 
 
Picot A, Lacroix C. 2004. Encapsulation of bifidobacteria in whey protein-based microcapsules 
and survival in simulated gastrointestinal conditions and in yoghurt. Int.Dairy J. 14(6):505-15.  
Picot A, Lacroix C. 2003. Optimization of dynamic loop mixer operating conditions for 
production of o/w emulsion for cell microencapsulation. Lait 83(3):237-50.  
Robinson RK. 1987. Survival of Lactobacillus acidophilus in fermented products. Suid-
Afrikaanse Tydskrif vir Suiwelkunde 19(1):25-7.  
Saavedra J, Bauman N, Oung I, Perman J, Yolken R. 1994. Feeding of Bifidobacterium-Bifidum 
and Streptococcus-Thermophilus to Infants In-Hospital for Prevention of Diarrhea and Shedding 
of Rotavirus. Lancet 344(8929):1046-9.  
Shah NP. 2000. Some beneficial effects of probiotic bacteria. Bioscience and Microflora 
19(2):99-106.  
Shah NP. 2007. Functional cultures and health benefits. Int.Dairy J. 17(11):1262-77.  
Shah N, Lankaputhra W, Britz M, Kyle W. 1995. Survival of Lactobacillus-Acidophilus and 
Bifidobacterium-Bifidum in Commercial Yogurt during Refrigerated Storage. Int.Dairy J. 
5(5):515-21.  
Teixeira P, Castro M, Malcata F, Kirby R. 1995. Survival of Lactobacillus-Delbrueckii Ssp 
Bulgaricus Following Spray-Drying. J.Dairy Sci. 78(5):1025-31.  
Vidhyalakshmi R, Bhakyaraj R, Sub hasree RS. 2009. Encapsulation “the future of probiotics”. 
Advances in Biological Research. 3(3-4):96-103. 
 
 
 
 
 
 
 
60 
 
4.7 Tables and Figures  
FIGURE 4.1 Flow diagram of microencapsulation process. 
 
 
TABLE 4.1 Operation conditions for spray drying. 
Inlet air temperature 160°C 
Outlet air temperature 90°C 
Feed rate 10 kg/hr 
Feed temperature 40°C 
Atomizer rotation speed for centrifugal atomization 20,000 rpm 
Air pressure for two-fluid nozzle atomization 344.7 kPa (50 psi) 
Wet bulb and dry bulb temperature (average) Twb: 21.2°C;Tdb: 29.6°C 
Relative humidity (range for all samples) 37.5-59%  
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TABLE 4.2 Viability of B. infantis on each step during encapsulation process. 
 SPC + atomizer WPC + atomizer SPC + nozzle WPC + nozzle 
Initial cell 3.29E+08
b
 1.52E+09
a
 2.27E+09
a
 7.98E+08
a
 
Oil dispersion 6.60E+07
c
 6.03E+08
b
 5.31E+08
b
 1.26E+08
b
 
Homogenization 9.16E+08
a
 1.43E+09
a
 1.86E+09
a
 1.05E+09
a
 
Spray drying 7.14E+06
c
 1.13E+07
c
 5.70E+07
b
 5.01E+06
b
 
All values are in CFU/mL. Different superscripts indicate significant differences (α=0.05). 
Atomizer means the centrifugal atomizer and nozzle means two-fluid nozzle.   
 
 
FIGURE 4.2 Viability of B. infantis after encapsulation process.  
 
Different superscripts indicate significant difference (α = 0.05) in numbers between initial and 
after spray drying process for each sample. Atomizer means the centrifugal atomizer and nozzle 
means two-fluid nozzle. 
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FIGURE 4.3 Mean reduction of B. infantis after encapsulation process. 
 
 
Different superscripts indicate significant differences (α=0.05) in numbers. Atomizer means the 
centrifugal atomizer and nozzle means two-fluid nozzle. 
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FIGURE 4.4 Viable counts changes of B. infantis during storage. 
 
Data were averaged. Atomizer means the centrifugal atomizer and nozzle means two-fluid 
nozzle. Control is non-encapsulated B. infantis mixed with soybean oil. 
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TABLE 4.3 Relative humidity (RH) of ambient air during encapsulation process.  
Sample RH (%) Sample  RH (%) 
1) SPC + atomizer 37.5 5) SPC + atomizer 52.9 
2) SPC + nozzle 43.1 6) SPC + nozzle 48.4 
3) WPC + atomizer 45.6 7) WPC + atomizer 47.9 
4) WPC + nozzle 41.6 8) WPC + nozzle 46.2 
Atomizer means the centrifugal atomizer and nozzle means two-fluid nozzle.   
 
FIGURE 4.5 Viable counts change of B. infantis in simulated gastrointestinal model. 
 
Atomizer means the centrifugal atomizer and nozzle means two-fluid nozzle.  
Peps. (pepsin, simulated gastric juice). Panc. (pancreatin, simulated small intestinal juice). 
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FIGURE 4.6 Viability of B. infantis after simulated gastrointestinal model test. 
 
Different superscripts indicate significant difference (α = 0.05) in numbers between after spray 
drying and after 3H in small intestinal juice for each sample. Atomizer means the centrifugal 
atomizer and nozzle means two-fluid nozzle. 
 
 
 
 
 
 
 
 
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
spc+atomizer wpc+atomizer spc+nozzle wpc+nozzle control w/ oil
After spray drying
After 3H in small
intestinal juice
M
e
an
 C
FU
/m
l (
lo
g 
sc
al
e)
 
a 
a 
a 
a 
b 
b 
b 
b 
Detection limit 
66 
 
FIGURE 4.7 Mean reduction of B. infantis after simulated gastrointestinal model test.  
 
 
Different superscripts indicate significant differences (α=0.05) in numbers. Atomizer means the 
centrifugal atomizer and nozzle means two-fluid nozzle. 
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FIGURE 4.8 Viability of B. infantis and LA-5 after encapsulation process. 
 
Different superscripts indicate significant difference (α = 0.05) in numbers between initial and 
after spray drying process for each sample. Nozzle means two-fluid nozzle. 
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FIGURE 4.9 Mean reduction of B. infantis and LA-5 after encapsulation process. 
 
Different superscripts indicate significant differences (α=0.05) in numbers. Nozzle means two-
fluid nozzle. 
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FIGURE 4.10 Viable counts changes of LA-5 (wpc+nozzle) in simulated gastrointestinal model. 
  
Nozzle means two-fluid nozzle. Peps. (pepsin, simulated gastric juice). Panc. (pancreatin, 
simulated small intestinal juice). 
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FIGURE 4.11 Viability of B. infantis and LA-5 after simulated gastrointestinal model test. 
 
Different superscripts indicate significant difference (α = 0.05) in numbers between after spray 
drying and after 3H in small intestinal juice for each sample. Nozzle means two-fluid nozzle. 
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FIGURE 4.12 Viability of B. infantis and LA-5 after simulated gastrointestinal model test. 
 
Different superscripts indicate significant differences (α=0.05) in numbers. Nozzle means two-
fluid nozzle. 
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FIGURE 4.13 Scanning electron micrographs of encapsulated B. infantis (A-D) and LA-5 (E). 
(A) SPC with centrifugal atomization                   (B) SPC with two-fluid nozzle atomization 
  
(C) WPC with centrifugal atomization                  (D) WPC with two-fluid nozzle atomization 
      
(E) WPC with two-fluid nozzle atomization (LA-5)  
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Chapter 5. Summary  
In this study, two different atomization methods (centrifugal atomization and two-fluid 
nozzle atomization) and wall matrices (SPC and WPC) were tested to determine an optimal 
microencapsulation process for probiotics. Based on the results, microencapsulation was 
significantly effective on viability of E. lactis compared to non-encapsulated one during 
encapsulation process and storage. Viability of encapsulated E. lactis was maintained during 
long-term storage (25 weeks) with less than 1 log reduction. In terms of atomization method, 
two-fluid nozzle atomization protected the E. lactis significantly better than centrifugal 
atomization during long-term storage. Effects of the wall matrices were not significant during 
encapsulation process and storage.  
Microencapsulation of probiotics with B. infantis and LA-5 was conducted to evaluate 
the effect of microencapsulation on viability of probiotics for storage and simulated 
gastrointestinal tract. Results showed that encapsulated B. infantis maintained viable counts 
significantly longer than non-encapsulated B. infantis during storage and simulated GI tract. 
WPC and two-fluid nozzle atomization showed significantly less reduction in viable counts of B. 
infantis during simulated GI tract.  
The findings from this study are important that it developed an optimal encapsulation 
process for B. infantis, which are naturally weaker than LA-5, to be comparable in viability with 
encapsulated LA-5 which are widely used probiotic strains due to their strong survivability. 
Therefore, the applicability of B. infantis in food products could be expanded with this 
microencapsulation method. Future work should include investigations of factors which could 
affect degradation of encapsulated probiotics during storage and also application of encapsulated 
probiotics in food matrices such as orange juice, yogurt and cereal bar.  
